ZURICH/BERLIN, Feb 17 (Reuters) - Here are some of the main
factors that may affect Swiss stocks on Thursday:
NESTLE SA NESN.S
Full-year results due.
LONZA LONN.S
An Omicron-specific booster could be ready by August, the
CEO of U.S. biotech firm Moderna MRNA.O told Reuters, but the
firm is still gathering clinical data to determine whether that
vaccine would offer better protection than a new dose of the
existing jab. In Europe, Moderna produces its vaccines through
manufacturing partnerships which include Lonza LONN.S .
COMPANY STATEMENTS
* Intershop ISN.S says Chairman Dieter Marmet will not
seek reelection, board member Ernst Schaufelberger set to
succeed him
ANALYSTS' VIEWS
TEMENOS AG TEMN.S : JP MORGAN CUTS TARGET PRICE TO CHF 135
FROM CHF 165
ALCON AG ALCC.S : JP MORGAN CUTS TARGET PRICE TO CHF 69
FROM CHF 72.20
SCHINDLER HOLDING AG SCHP.S : CREDIT SUISSE CUTS TARGET
PRICE TO CHF 280 FROM CHF 305
SCHINDLER HOLDING AG SCHP.S : JP MORGAN CUTS TARGET PRICE
TO CHF 260 FROM CHF 280
ECONOMY
Swiss January trade balance due at 0700 GMT
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))